Company Filing History:
7 out of 7 
1 out of 1,929 
Years Active: 2003-2013
Title: The Innovations of Norman M Kneteman
Introduction
Norman M Kneteman is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medical research, particularly in the development of animal models for studying human diseases. With a total of 7 patents, Kneteman's work has advanced our understanding of viral infections and therapeutic interventions.
Latest Patents
One of Kneteman's latest patents is titled "Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection." This invention features a non-human animal model that is susceptible to infection by human hepatotrophic pathogens, particularly the human hepatitis C virus (HCV). The model is based on a non-human, immunocompromised transgenic animal that possesses a human-mouse chimeric liver. The transgene allows for the expression of a urokinase-type plasminogen activator in the liver. This invention also includes methods for identifying candidate therapeutic agents, such as those with antiviral activity against HCV infection. Additionally, the animals created through this invention are useful for assessing the toxicity of various agents and evaluating the activity of agents in reducing blood lipids.
Career Highlights
Throughout his career, Kneteman has worked with various organizations, including Kmt Hepatech, Inc. and the University System of Maryland. His research has focused on creating innovative solutions to complex medical challenges, particularly in the realm of liver diseases and viral infections.
Collaborations
Kneteman has collaborated with esteemed colleagues such as D Lorne Tyrrell and David Frederick Mercer. These partnerships have further enriched his research and contributed to the advancement of medical science.
Conclusion
Norman M Kneteman's contributions to medical research through his innovative patents and collaborations have made a significant impact in the field. His work continues to pave the way for new therapeutic approaches to combat viral infections.